FTK Shorts Build as ProFrac Overhang Looms Over Earnings

Flotek Industries reports Q3 results on November 4 with short sellers adding pressure and a controlling shareholder's recent divestiture still fresh in the market's memory.

Short interest has climbed sharply heading into the print. It has risen 12.4% over the past week to reach 14.4% of the free float, one of the more elevated readings in the specialty chemicals space. That is a meaningful build in bearish positioning. Availability in the lending pool has tightened at the same time, dropping to 37.9% from above 58% a month ago, suggesting growing demand for borrows. The ORTEX short score is running at 78.3, ranking in the bottom 1% of the broader universe on that measure. Borrowing costs remain low at 0.86%, so there is no acute squeeze pressure, but the direction is unambiguous. The stock is trading at $24.84, down nearly 20% over the past month despite a 5.8% bounce in the most recent session.

Options traders are leaning the other way. The put/call ratio has fallen to 0.30, more than a standard deviation below its 20-day average of 0.36, placing it nearer the bearish end of its 52-week low of 0.09 than its high of 0.49. That gap between rising short positioning and call-heavy options flow is the central tension in the setup: short sellers are adding but options participants are not paying for downside protection at the same rate.

The ownership picture adds a complicating layer. ProFrac Holding Corp. is on the Schedule 13D register as an activist holder, with the most recent filing showing its stake at 54.5% of the class, reduced from 61.1%. In September, ProFrac-linked entity ProFrac GDM sold 2.3 million shares for $60 million at $26.01, while director Matthew Wilks simultaneously purchased 1.3 million shares for $34.3 million at the same price, a partial transfer rather than outright disposal. Net insider activity over the past 90 days is negative at roughly negative $25.7 million. The October 30 tax-withholding transactions by the CEO and CFO were mechanical, not discretionary. Stakes are as last disclosed around the 5% threshold, and holders can exit below that level without further filing.

Analyst coverage is positive but dated. The most recent price target move was Lake Street raising its target to $44 in mid-September, and Jones Trading initiated at $40 in July. The mean target across coverage sits around $38.92 against a current price of $24.84, implying material upside on paper. However, these targets predate the recent 20% decline and should be treated with some caution as fresh data for the print. The company has a strong EPS surprise track record, ranking in the 93rd percentile on that factor. Earnings history is mixed: the August 2026 print produced a 29% one-day gain, while the subsequent report in August triggered a 1.8% fall and a 4.6% drop over the following five days.

The print will test whether Flotek's underlying revenue trajectory justifies the gap between current market price and analyst targets, and whether the controlling shareholder's ongoing stake reduction is a source of future supply or the conclusion of a planned restructuring.